Home > Boards > US OTC > Biotechs > NorthWest Biotherapeutics Inc. (NWBO)

flipper, I think FDA is really running this

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (7) | Next 10 | Previous | Next
marzan Member Profile
 
Followed By 39
Posts 8,317
Boards Moderated 1
Alias Born 07/10/14
160x600 placeholder
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/15/2020 4:54:03 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/3/2020 5:04:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/13/2019 4:25:29 PM
Citation Growth Corp. (OTCQX: CGOTF) Weathering the Cannabis Downturn InvestorsHub NewsWire - 12/9/2019 7:23:11 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/12/2019 5:19:23 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 11/1/2019 6:00:56 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/28/2019 5:12:01 PM
On Watch this Week with Near-Term Potential Catalysts InvestorsHub NewsWire - 10/21/2019 8:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/18/2019 5:28:26 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 10/18/2019 1:09:37 PM
CLS Holdings (CLSH) Record Sales Just Reported - Most Undervalued Cannabis Stocks InvestorsHub NewsWire - 9/10/2019 7:00:09 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/9/2019 4:22:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/22/2019 5:05:19 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 7/18/2019 6:02:10 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 7/17/2019 5:24:27 PM
Biotech Companies with Recent and Potential Near-Term Catalysts InvestorsHub NewsWire - 7/15/2019 8:15:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/28/2019 12:11:21 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 5:24:36 PM
Annual Report (10-k) Edgar (US Regulatory) - 4/2/2019 5:23:33 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) Edgar (US Regulatory) - 3/19/2019 5:19:39 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 3:33:33 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 3:20:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/7/2019 5:26:54 PM
marzan   Tuesday, 10/22/19 06:44:31 AM
Re: flipper44 post# 248545
Post # of 261430 
flipper, I think FDA is really running this trial. They put a hold on it in 2015 and lifted it in 2017. They are tracking this trial much more than you and us the other board members here. They want OS 4yr the last person vaccinated timeline to complete before they ok the SAP. If they ok it ahead, you and I know what we will demand: unblind at once. But FDA wants to make sure they have the real fat flat OS tail, not the predicted k-m tail. This is all my hypothesis. AMRN management goes against the FDA, takes them to court but LP never likes to make them mad. She protects them never discloses their shortfalls like the hold on us. This is also my opinion. So, even if we take the issue to FDA, there is going to be no use, imo, because you know what I mean: FDA is the player here.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (7) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist